Daily Judi: Tuesday, December 20, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
The U.S. Government Accountability Office released a report on the actions of both federal agencies and non-federal cancer centers on increasing diversity in oncology clinical trials.
Yale School of Medicine’s Jennifer Miller, Reshma Ramachandran, and Tanvee Varma discuss the need for U.S. congressional policy to help create a more diverse clinical trial patient population. (Bloomberg Law)
An analysis by the SWOG Cancer Research Network and published in the Journal of Clinical Oncology estimates that adult cancer trials from the last 40 years within the National Cancer Institute's (NCI's) National Clinical Trials Network (NCTN) extended the lifespan for U.S. patients by over 14 million life-years, with the federal investment for each year added to a patient's life at just over $300. (Medical Xpress)
Our Culture
“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.